Search Results

You are looking at 1 - 10 of 466 items for :

Clear All
Open access

Raymond J Rodgers, Jodie C Avery, Vivienne M Moore, Michael J Davies, Ricardo Azziz, Elisabet Stener-Victorin, Lisa J Moran, Sarah A Robertson, Nigel K Stepto, Robert J Norman and Helena J Teede

associated risk of gestational diabetes (GDM), impaired glucose tolerance, type 2 diabetes (DM2), non-alcoholic fatty liver disease (NAFLD), dyslipidaemia and increased risk factors for both cerebrovascular and cardiovascular disease ( 6 , 7 , 8 , 9

Open access

Ann-Kristin Picke, Graeme Campbell, Nicola Napoli, Lorenz C Hofbauer and Martina Rauner

Introduction The prevalence of diabetes mellitus is increasing worldwide with diabetes-related complications accounting for up to 60–70% of health-care costs related to diabetes ( 1 , 2 ). Besides the well-known renal and cardiovascular

Open access

Monia Cito, Silvia Pellegrini, Lorenzo Piemonti and Valeria Sordi

Introduction Type 1 diabetes (T1D) is an autoimmune disorder characterized by insulin-producing β cell death caused by autoreactive T cells ( 1 ). T1D contributes to 10% of the total 422 million diabetes cases worldwide. Although T1D is no

Open access

Helga Schultz, Svend Aage Engelholm, Eva Harder, Ulrik Pedersen-Bjergaard and Peter Lommer Kristensen

(MSCC) and brain tumours. Diabetes mellitus (DM) is a well-known metabolic side effect from treatment with glucocorticoids. The diabetogenic effect is mainly a result of insulin resistance in muscle and fatty tissue, increased production of glucose from

Open access

Metin Guclu, Sinem Kiyici, Zulfiye Gul and Sinan Cavun

Introduction Excess weight and weight gain are significant problems in the treatment of patients with type 2 diabetes mellitus ( 1 ). Weight reduction is a critical part of type 2 diabetic patients’ management to obtain better glycemic control

Open access

A V Dreval, I V Trigolosova, I V Misnikova, Y A Kovalyova, R S Tishenina, I A Barsukov, A V Vinogradova and B H R Wolffenbuttel

glucose anomalies in these patients are now known to include diabetes mellitus (DM), impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) and have been discussed extensively in a review by Colao et al . (2) . Looking more specifically at

Open access

Jairo Arturo Pinzón-Cortés, Angelina Perna-Chaux, Nicolás Steven Rojas-Villamizar, Angélica Díaz-Basabe, Diana Carolina Polanía-Villanueva, María Fernanda Jácome, Carlos Olimpo Mendivil, Helena Groot and Valeriano López-Segura

Introduction Type 2 diabetes mellitus (T2DM) is a complex disease characterized by hyperglycemia secondary to inappropriate insulin secretion, resistance to its action, or both. Over time, these alterations and oxidative stress promote the

Open access

Taísa A R Vicente, Ívina E S Rocha, Roberto Salvatori, Carla R P Oliveira, Rossana M C Pereira, Anita H O Souza, Viviane C Campos, Elenilde G Santos, Rachel D C Araújo Diniz, Eugênia H O Valença, Carlos C Epitácio-Pereira, Mario C P Oliveira, Andrea Mari and Manuel H Aguiar-Oliveira

, especially in subjects older than 23 years, with a case of diabetes mellitus (DM) diagnosed in a 38-year-old patient due to βCF exhaustion (7) . However, recently, in a large Ecuadorian study of kindred with Laron syndrome, none of the GH

Open access

Xiao-jun Zhou, Lin Ding, Jia-xin Liu, Le-qun Su, Jian-jun Dong and Lin Liao

Introduction Diabetes, as one of the largest global health emergencies in the 21st century, has increased with a burgeoning trend. The latest International Diabetes Federation (IDF) Diabetes Atlas indicated that in 2016 the estimated number of

Open access

Alessandra Gambineri and Carla Pelusi

Role of sex and gender on the development of type 2 diabetes There is increasing evidence that sex and gender differences influence the epidemiology, pathophysiology, treatment and outcomes of many diseases, including type 2 diabetes (T2DM